Ethylenediamine → HCID 71255305、化合物

反応式

[CH2:1]1[C:7]2[CH:8]=[CH:9][CH:10]=[CH:11][C:6]=2[CH2:5][CH2:4][CH2:3][NH:2]1.Cl[C:13]1[CH:22]=[C:21](Cl)[C:20]2[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=2)[N:14]=1.[CH3:24][N:25]([CH3:29])[CH2:26][CH2:27][NH2:28].ClC1C=C(Cl)C2C(=CC=C(Cl)C=2)N=1.C(N)CN>>[CH3:24][N:25]([CH3:29])[CH2:26][CH2:27][NH:28][C:21]1[C:20]2[C:15](=[CH:16][CH:17]=[CH:18][CH:19]=2)[N:14]=[C:13]([N:2]2[CH2:3][CH2:4][CH2:5][C:6]3[CH:11]=[CH:10][CH:9]=[CH:8][C:7]=3[CH2:1]2)[CH:22]=1

参加物

反応物 5

HCID 3301Ethylenediamine

HCID 66053N,N-Dimethylethylenediamine

HCID 6075032,4-Dichloroquinoline

HCID 104644722,3,4,5-tetrahydro-1H-2-benzazepine

HCID 187966912,4,6-Trichloroquinoline

生成物 1

HCID 71255305HCID 71255305、化合物

実験手順

The title compound was prepared in analogy to Example 118-1 in Scheme 59 by using 2,3,4,5-tetrahydro-1H-2-benzazepine (commercial available), 2,4-dichloroquinoline (commercial available) and N,N-dimethyl-ethane-1,2-diamine (commercial available) instead of 7-bromo-2,3,4,5-tetrahydro-1H-2-benzazepine, 2,4,6-trichloroquinoline and ethane-1,2-diamine respectively. MS obsd. (ESi+) [(M+H)+] 361. 1H NMR (400 MHz, DMSO-d6) δ ppm 7.90 (d, J=3.6 Hz, 1 H), 7.56-7.46 (m, 3 H), 7.15-7.11 (m, 4 H), 5.89 (s, 1 H), 4.87 (s, 2 H), 4.14 (s, 2 H), 3.53 (s, 2 H), 3.05 (s, 2 H), 2.91 (s, 2 H), 2.53 (s, 6 H), 1.80 (s, 2 H).